Atlas Trials

Study of XNW5004 Tablets in Advanced Prostate Cancer

Clinical trial NCT07730580 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07730580
Sponsor
Evopoint Biosciences Inc.
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Advanced Prostate Cancer
Start date
2026-07-13
Primary completion
2028-12-31
Enrollment
242

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.